Author:
García-López P,Martínez-Cruz A,Guízar-Sahagún G,Castañeda-Hernández G
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology,General Medicine
Reference25 articles.
1. Segal JL, Brunnemann SR . Clinical pharmacokinetics in patients with spinal cord injury. Clin Pharmacokinet 1989; 17: 109–129.
2. Sankaranarayanan A, Hemal AK, Pathak CM, Vaidyanathan S . Serum gentamicin levels in traumatic paraplegics following intramuscular administration in non-paralyzed limbs. Int J Clin Pharmacol Ther Toxicol 1989; 27: 540–543.
3. García-López P, Salas R . Bioavailability of diclofenac after intramuscular administration to rats with experimental spinal cord injury. J Pharmacol Toxicol Methods 1999; 42: 99–101.
4. Lavezo LA, Davis RL . Vancomycin pharmacokinetics in spinal cord injured patients: a comparison with age-matched, able-bodied controls. J Spinal Cord Med 1995; 18: 233–235.
5. Segal JL, Brunnemann SR, Eltorai IM, Vulpe M . Decreased systemic clearance of lorazepam in humans with spinal cord injury. J Clin Pharmacol 1991; 37: 651–666.